Effect of Crocin on non-alcoholic fatty liver disease
Phase 3
Recruiting
- Conditions
- non-alcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classified
- Registration Number
- IRCT20180513039634N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
> 18 years old
Patient with NAFLD (according to ultrasonography and high level of AST and ALT)
Exclusion Criteria
Viral and autoimmune hepatitis
Metabolic liver disease, alcohol and drug consumption
Pharmacotherapy for NAFLD
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ALT. Timepoint: Before intervention and 8 weak after intervention. Method of measurement: Enzymatic photometery.;AST. Timepoint: Before intervention and 8 weak after intervention. Method of measurement: Enzymatic photometery.;TC, TG, LDL, HDL. Timepoint: Before intervention and 8 weak after intervention. Method of measurement: Enzymatic photometry.
- Secondary Outcome Measures
Name Time Method